Wealth Management Associates, Inc. Sangamo Therapeutics, Inc Transaction History
Wealth Management Associates, Inc.
- $257 Billion
- Q2 2025
A detailed history of Wealth Management Associates, Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 307,800 shares of SGMO stock, worth $209,304. This represents 0.06% of its overall portfolio holdings.
Number of Shares
307,800
Previous 228,400
34.76%
Holding current value
$209,304
Previous $150 Million
11.23%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding SGMO
# of Institutions
126Shares Held
50.9MCall Options Held
1.1MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$6.37 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$5.5 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$4.65 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$3.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.59 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $106M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...